Advanced in Age-Related Macular Degeneration (ARMD)

Alan R. Berger

St. Michael's Hospital/Unity Health Toronto
Toronto, ON, CA 
Advanced in Age-Related Macular Degeneration (ARMD)
St. Michael's Hospital/Unity Health Toronto
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Alan Berger practices in Toronto, Canada. Mr. Berger is rated as an Advanced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Diabetic Macular Edema (DME), Late-Onset Retinal Degeneration, and Vitrectomy.

His clinical research consists of co-authoring 53 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 16 articles in the study of Age-Related Macular Degeneration (ARMD).

Gender
Male

Locations

St. Michael's Hospital/Unity Health Toronto
Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised Controlled Trial Comparing Pneumatic Retinopexy Versus Vitrectomy for the Management of Primary Retinal Detachment; Anatomical Success, Functional Success and Impact on Patient Quality of Life
A Randomised Controlled Trial Comparing Pneumatic Retinopexy Versus Vitrectomy for the Management of Primary Retinal Detachment; Anatomical Success, Functional Success and Impact on Patient Quality of Life
Enrollment Status: Completed
Publish Date: September 18, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema: The COLLIDE Trial
Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema: The COLLIDE Trial
Enrollment Status: Terminated
Publish Date: August 20, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

53 Total Publications

Clinical and Demographic Risk Factors Associated with Recurrent and Fellow Eye Rhegmatogenous Retinal Detachments.
Clinical and Demographic Risk Factors Associated with Recurrent and Fellow Eye Rhegmatogenous Retinal Detachments.
Journal: Retina (Philadelphia, Pa.)
Published: August 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Berger's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile